autograft can a novel therapeutic approach to increasing serum testosterone while simultaneously preserving fertility.
INTRODUCTION AND OBJECTIVES: Spermatogonial stem cells (SSCs) are essential for the generation of sperm, an event that occurs throughout adult life. Moreover, SSCs have therapeutic potential. A prime application for SSC transplantation is cancer survivors who went through gonadotoxic therapy during their prepubertal period, and thus no mature sperm could be cryopreserved prior to treatment. Despite the importance of human SSCs, remarkably little is known about them, including the mechanisms driving their self-renewal and expansion. Here, we demonstrate effective ways to culture, expand, and manipulate gene expression in human SSCs.
METHODS: Human testicular biopsies were obtained from fertile donors and cultured either as slices (organ culture) or as dispersed cells. RHOXF2 was depleted using a RHOXF2 small hairpin (sh) RNA that we cloned into a lentiviral vector. Immunostaining, FACS, and quantitative (q) RT-PCR were used to assess gene expression.
RESULTS: Human testicular organ cultures exhibited a modest increase in SSC and spermatogonia markers and a dramatic decline in advanced germ cell markers (Fig. 1A ). This suggests a proliferative expansion of spermatogonia, including SSCs, and loss of more differentiated germ cells. Cultured dissociated germ cells exhibited a similar pattern of marker expression except that advanced germ cell markers did not decline in level (Fig. 1B) . Clusters of germ cells were observed in these cultures, possibly indicative of proliferative expansion (Fig. 1C ). FACS analysis with the human SSC marker, SSEA4, revealed that both culture conditions increased the number of SSEA4+ cells, confirming expansion of SSCs/undifferentiated spermatogonia. Lentivirus infection with a RHOXF2 shRNA successfully depleted RHOXF2 expression (Fig. 1D) 
INTRODUCTION AND OBJECTIVES:
Telemedicine is gaining in popularity and has demonstrable efficacy in carrying out patient interviews over a video-conference system. The amenability of telemedicine to evaluate prostate cancer at various stages of disease has not yet been studied. Our primary objective was to evaluate patient satisfaction in the evaluation of patients with prostate cancer at various stages using telemedicine encounters (TME).
METHODS: We performed a retrospective review of 424 consecutive TME at an urban academic urology practice carried out from its inception in October 2015 to August 2016; 219 patients (52%) completed our satisfaction survey. After each encounter, patients were asked to rate their satisfaction with their provider and of their use of a HIPAA-compliant video-conference system separately on a Likert scale of 1 to 5, with 5 being the most favorable and 1 being the least favorable. Of patients who completed the survey, 30 individual TME had prostate cancer as the primary diagnosis. These TME were separated according to the reason for each TME, and the mean (m) satisfaction scores were calculated for each reason. ANOVA testing was used to determine significant difference in patient satisfaction based on reason for TME.
RESULTS: The breakdown of the 30 encounters is as depicted in Table 1 . There was no significant difference in satisfaction between the reasons for each visit [patient-provider satisfaction (PPS) p¼ 0.27; Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e193
